Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | P |
| Molecular Weight | 30.973762 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[P]
InChI
InChIKey=XYFCBTPGUUZFHI-UHFFFAOYSA-N
InChI=1S/H3P/h1H3
| Molecular Formula | P |
| Molecular Weight | 30.973762 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Phosphorus is a chemical element with symbol P and atomic number 15. Phosphorus is essential for life (compounds containing the phosphate ion) are a component of DNA, RNA, ATP, and phospholipids. Elemental phosphorus exists in many allotropic forms, three major allotropes are white, red and black. Red phosphorus is a component of matchbook strike plates and is used as an ingredient in certain commercial rat and cockroach poisons. Red phosphorus is used in the manufacture of pyrotechnics, safety matches, semiconductors, fertilizers, pesticides, incendiary shells, smoke bombs, and tracer bullets. It is also used in organic synthesis reactions and in the manufacture of phosphoric acid, phosphine, phosphoric anhydride, phosphorus pentachloride, and phosphorus trichloride. Red phosphorus is also used in electroluminescent coatings and in flame retardants for polymers.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cholestatic presentation of yellow phosphorus poisoning. | 2014-01 |
|
| Phosphorous dysregulation induced by MEK small molecule inhibitors in the rat involves blockade of FGF-23 signaling in the kidney. | 2012-01 |
|
| X-ray fluorescence analysis of long-term changes in the levels and distributions of trace elements in the rat brain following mechanical injury. | 2011-02 |
|
| Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. | 2007-11 |
|
| Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. | 2007-11 |
|
| Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins. | 2007-06 |
|
| Disruption of iron homeostasis increases phosphine toxicity in Caenorhabditis elegans. | 2007-03 |
|
| Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. | 2006-01 |
|
| Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. | 2005-12 |
|
| [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. | 2005-09 |
|
| Functional characteristics of NaS2, a placenta-specific Na+-coupled transporter for sulfate and oxyanions of the micronutrients selenium and chromium. | 2005-01-25 |
|
| Major and trace elements in whole blood of phlebotomized patients with porphyria cutanea tarda. | 2005 |
|
| FGF-23 is elevated by chronic hyperphosphatemia. | 2004-09 |
|
| A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. | 2004-09 |
|
| Electrolyte concentrations in saliva of children aged 6-10 years with Down syndrome. | 2004-07 |
|
| Expression of collagen XVIII and MMP-20 in developing teeth and odontogenic tumors. | 2004-06 |
|
| Beneficial effect of liver transplantation on bone mineral density in small infants with cholestasis. | 2004-06 |
|
| Neural damage due to temporal lobe epilepsy: dual-nuclei (proton and phosphorus) magnetic resonance spectroscopy study. | 2004-02 |
|
| Relation of salivary inorganic phosphorus and alkaline phosphatase to the dental caries status in children. | 2003-12 |
|
| Calcification mimicking manganese-induced increased signal intensities in T1-weighted MR images in a patient taking herbal medicine: case report. | 2003-12 |
|
| Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. | 2003-12 |
|
| A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan. | 2003-08-29 |
|
| Calcimimetic agents: review and perspectives. | 2003-06 |
|
| Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. | 2003-01-24 |
|
| Pathogenesis and treatment of renal osteodystrophy. | 2003 |
|
| Effects of PHEX antisense in human osteoblast cells. | 2002-02 |
|
| Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. | 2002-02 |
|
| Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. | 2001-09 |
|
| 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease. | 2001-05 |
|
| Chromosome rearrangements in fumigant appliers: possible relationship to non-Hodgkin's lymphoma risk. | 1992-05-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:20 GMT 2025
by
admin
on
Mon Mar 31 18:12:20 GMT 2025
|
| Record UNII |
27YLU75U4W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
102 (Number of products:3512)
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
||
|
NCI_THESAURUS |
C1940
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
||
|
EPA PESTICIDE CODE |
66502
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
||
|
CFR |
21 CFR 862.1580
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
28659
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
1169
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
SUB14855MIG
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
27YLU75U4W
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
35895
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
D010758
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
DB14151
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
27YLU75U4W
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
DTXSID1024382
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
8263
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | RxNorm | ||
|
m8729
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | Merck Index | ||
|
phosphorus
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
231-768-7
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
C68277
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
7723-14-0
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
5462309
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY | |||
|
100000091774
Created by
admin on Mon Mar 31 18:12:20 GMT 2025 , Edited by admin on Mon Mar 31 18:12:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |